AFAP1 and non-small cell lung carcinoma: Nowadays, lncRNA is recognized as a pervading factor that participates in cell proliferation, differentiation, apoptosis, and carcinogenesis.[8] For example, AFAP1-AS1 indicates a poor prognosis and regulates NSCLC cells by repressing p21 expression, and may serve as a therapeutic target for human NSCLC.[9] Furthermore, lncRNAs have therapeutic potential, strategies are being developed based on molecules that are designed to disrupt the expression or functionality of these lncRNAs.[10]